Updates

Innovation

March 2010

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

A Q1 trading statement said that although the business is traditionally weighted to the second half, things are generally on track. The group is making good progress towards winning and establishing new customers with a substantial number of pilot (proof of concept) projects underway across their geographic operations. The largest of these are in the UK, US and South Africa and the potential contract size is increasing up to Â£5m per annum. But there will be a Â£3m exceptional charge, with H1 results to cover two underperforming regions although this will generate savings in H2 and beyond. As Panmure quip, â€œif the new CEO, Andy Roberts, wasn't restructuring the perennial disappointer we would be disappointed.â€ ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

OPG Power - Excellent buy opportunity

BATM - Medical side growing fast

Innovation (October 2015)

Innovation (May 2015)

Innovation (January 2015)

Innovation (September 2014)

Innovation - LAS moves iy into huge "wet" perils market (June 2014)

Innovation (September 2012)

Innovation (January 2012)

Innovation - New contract wins (November 2011)

Innovation (September 2011)

Innovation Group - Targeting building claims alongside core motor claims business (June 2011)

Innovation Group (May 2011)

Innovation Group (January 2011)

Innovation (September 2010)

Innovation Group - Â£21m fundraising at 10p (January 2010)

Innovation (September 2009)

Innovation (June 2009)

Innovation - Two contracts worth Â£4m (May 2009)

Innovation Group - In play (April 2009)

Innovation Group - Q1 sales +17.5% (organic) (March 2009)

Innovation - New customer wins (February 2009)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X